LIPOPROTEIN METABOLISM DISORDERS AND HEREDITARY NEUROLOGICAL DISEASE: BASSEN-KORNZWEIG SYNDROME
Abstract
The literature data about the association between low levels of lipids (gipoholesterinemia) with the occurrence of neurological disorders in children and adolescents at the present time remains controversial. A sharp decrease of the cholesterol, phospholipids, triglycerides, chylomicrons and apob levels or their absence leads to the development of abetalipoproteinemia (Bassen-Kornzweig syndrome). The key clinical symptoms of abetalipoproteinemia are psychomotor retardation, progressive cerebellar ataxia, pigment degeneration of the retina, peripheral neuropathy, as well as gross changes in the skeleton (severe scoliosis and pes cavus). Key laboratory signs - changes in the lipid spectrum (a sharp decrease of the blood levels of apob, total cholesterol, phospholipids, triglycerides, chylomicrons) and acanthocytes in the blood smear. The treatment is based on the replacement of fat-soluble vitamins and symptomatic therapy.
About the Author
A. V. Sukhanov
Research Institute of Therapy and Preventive Medicine
Russian Federation
Russian Federation
References
1. Денисенко А. Д., Маграчева Е. Я., Климов Л. Н. Сравнительная характеристика липопротеидов сосудистой стенки и плазмы крови человека // Кардиология. - 1976. - № 7. - С. 6
2. Полякова С. И. и др. Диагностика и лечение абеталипопротеинемии (клинический случай) //Российский педиатрический журнал. - 2012. - №. 4.
3. Суханов А. В. и др. Липидный профиль крови при болезни Альцгеймера в Сибири // Атеросклероз. 2011. Т. 7. № 2. С. 44-48.
4. Суханов А. В. и др. Молекулярно-генетические факторы риска болезни Альцгеймера // Журнал неврологии и психиатрии им. Корсакова. 2001. № 1. С. 65-68.
5. Bassen F. A., Kornzweig A. L. Malformation of the erythrocytes in a case of atypical retinitis pigmentosa // Blood. - 1950. - Vol. 5. - P. 381-387.
6. Benayoun, L., Granot, E., Rizel, L., Allon-Shalev, S., Behar, D. M., Ben-Yosef, T. Abetalipoproteinemia in Israel: evidence for a founder mutation in the Ashkenazi Jewish population and a contiguous gene deletion in an Arab patient. Molec. Genet. Metab. 90: 453-457, 2007.
7. Berriot-Varoqueaux N., Aggerbeck L., SamsonBouma M. Et al. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia // Annu. Rev. Nutr. - 2000. - Vol. 20. - P. 663-697.
8. Bostrom K., Wettesten M., Boren J. et al. Pulsechase studies of the synthesis and intracellular transport of apolipoprotein B-100 in Hep G2 cells // J. Biol. Chem. - 1986. - V. 261. - P. 13800-13806.
9. Druez G. Un nouveau cas d‘acanthocytose: dysmorphie erythrocytaire congenitale avec retinite, troubles nerveux et stigmates degeneratifs // Rev. Hemat., 1959. - Vol. 14. - P. 3-11.
10. Hoff H. F., Gaubatz J. W. Isolation, purification, and characterization of a lipoprotein containing apo B from the human aorta // Atherosclerosis. - 1982. - V. 42. - P. 273-282.
11. Jung H., Danek A., Walker R. Neuroacantocytosis syndromes // Orphanet. J. Rare Dis. - 2011. - Vol. 6. - P. 68-69.
12. Kane J. P. Apolipoprotein B: Structural and metabolic heterogeneity // Annu. Rev. Physiol. - 1983. - V. 45. - P. 637-650.
13. Kane J. P., Hardman D. A., PaulusH. E. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons // Proc. Natl. Acad. Sci. USA. - 1980. - V. 77. - P. 2465-2469.
14. Knott T. J., Rail S. C, Innerarity T. L. et al. Human apolipoprotein B: Structure of carboxylterminal domains, sites of gene expression, and chromosomal localization // Science. - 1985. - V. 230. - P. 37-43.
15. Krishnaiah K. V., Walker L. F., Borensztajn J. et al. Apolipoprotein B variant derived from rat intestine //. Proc. Natl. Acad. Sci. USA. - 1980 - V. 71. - P. 3806-3810.
16. Lee, J., Hegele, R. A. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. J. Inherit. Metab. Dis. 37: 333-339, 2014.
17. Linden T., Bondjers G., Fager G. et al. Apolipoprotein B in human aortic biopsies in relation to serum lipids and lipoproteins // Atherosclerosis. - 1989. - V. 77. - P. 159-166.
18. Modern nutrition in health and disease / Eds M. E. Shils et al. - 1994. http: www.vitamini.ru
19. Olofsson S.-O., BjursellG., BostrbmK. etal. Apolipoprotein B: structure, biosynthesis and role in the lipoprotein assembly process // Atherosclerosis. - 1987. - V. 68. - P. 1-17.
20. Rader D., Brewer H. Abetalipoproteinemia. New insights into liporotein assembly and vitamin E metabolism from a rare genetic disease // J. A. M. A. - 1993. - Vol. 270. - P. 865-869.
21. Singer K., Fisher B., Perlstein M. A. Acanthrocytosis (sic): a genetic erythrocytic malformation // Blood, 1952. - Vol. 7. - P. 577-591
22. Singh V. Low LDL Cholesterol (Hypobetalipoproteinemia) updated Jan 3, 2012. http://emedicine. Medscape.com/article/121975overview
23. Young S. G., Bertics S. /., Scott T. M. et al. Parallel expression of the MB19 genetic polymorphism in apoprotein B-100 and apoprotein B-48 // J. Biol. Chem. - 1986. -V. 261. - P. 2995-2998.
24. Zamel R., Khan R., Pollex R., Hendele R. Abetalip oproteinemia: two case reports and literature review // Orphanet. J. Rare Dis. - 2008. - Vol. 3. - P. 19-29.
Review
For citations:
Sukhanov A.V. LIPOPROTEIN METABOLISM DISORDERS AND HEREDITARY NEUROLOGICAL DISEASE: BASSEN-KORNZWEIG SYNDROME. Ateroscleroz. 2016;12(4):79-84. (In Russ.)
Views:
1150
Email this article 